Live from the NIH registry
Studies recruiting near Rock Hill right now
Top 25 of 593 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Atrium Health's Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: American Society of Clinical Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Presbyterian Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Myeloproliferative Neoplasm
N/A
Observational 35 participants sought
Atrium Health Levine Cancer — Charlotte, North Carolina (22.2 mi)
· Sponsor: Wake Forest University Health Sciences
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Novant Health Cancer Institute- Hematology — Charlotte, North Carolina (22.2 mi)
· Sponsor: Allogene Therapeutics
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Novant Health Presbyterian Medical Center ( Site 0177) — Charlotte, North Carolina (22.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Charlotte, North Carolina (22.2 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Monroe Biomedical Research — Monroe, North Carolina (27.0 mi)
· Sponsor: Genentech, Inc.
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (22.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
OrthoCarolina — Charlotte, North Carolina (22.2 mi)
· Sponsor: Elute, Inc.
Daoist Zhanzhuang and Human Flourishing
Stress, Physiological, Stress, Psychological
N/A
Interventional 120 participants sought
University of North Carolina at Charlotte — Charlotte, North Carolina (22.2 mi)
· Sponsor: University of North Carolina, Charlotte
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50238 — Charlotte, North Carolina (22.2 mi)
· Sponsor: UCB Biopharma SRL
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Levine Cancer Institute-Rock Hill — Rock Hill, South Carolina (1.2 mi)
· Sponsor: NRG Oncology
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: AstraZeneca
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: AstraZeneca
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
OnSite Clinical Solutions, LLC — Charlotte, North Carolina (22.2 mi)
· Sponsor: Pfizer
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Acute Myeloid Leukemia
N/A
Interventional 120 participants sought
Levine Cancer Insitute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Wake Forest University Health Sciences
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: Alnylam Pharmaceuticals
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
Atrium Health — Charlotte, North Carolina (22.2 mi)
· Sponsor: DARTNet Institute
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research — Charlotte, North Carolina (22.2 mi)
· Sponsor: Crystalys Therapeutics
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Multiple conditions
Phase 1
Interventional 46 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
Flourish Research — Matthews, North Carolina (20.9 mi)
· Sponsor: AC Immune SA
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
Musculoskeletal Injury
N/A
Observational 370 participants sought
Carolinas Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: Wake Forest University Health Sciences